(Q51361908)

English

Steroid-induced insulin resistance and impaired glucose tolerance are both associated with a progressive decline of incretin effect in first-degree relatives of patients with type 2 diabetes.

scientific article published in May 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/22286551

Steroid-induced insulin resistance and impaired glucose tolerance are both associated with a progressive decline of incretin effect in first-degree relatives of patients with type 2 diabetes. (English)

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/22286551

type 2 diabetes

0 references

1 reference

based on heuristic

inferred from title

insulin resistance

1 reference

based on heuristic

inferred from title

Jan Erik Henriksen

3

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/22286551

Jens Juul Holst

5

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/22286551

6

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/22286551

Benjamin A. H. Jensen

1

object named as

D H Jensen

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/22286551

author name string

K Aaboe

2

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/22286551

A Vølund

4

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/22286551

T Krarup

7

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/22286551

publication date

1 May 2012

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/22286551

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/22286551

55

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/22286551

5

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/22286551

1406-1416

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/22286551

https://scigraph.springernature.com/pub.10.1007/s00125-012-2459-7

0 references

The Physiology of Glucagon-like Peptide 1

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2459-7

21 January 2018

Nutrient, neural and endocrine control of glucagon-like peptide secretion

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2459-7

21 January 2018

Glucagon-like peptide-1, glucose homeostasis and diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2459-7

21 January 2018

Plasma Insulin Responses to Oral and Intravenous Glucose: Studies in Normal and Diabetic Subjects*

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2459-7

21 January 2018

Impact of incretin hormones on beta-cell function in subjects with normal or impaired glucose tolerance

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2459-7

21 January 2018

Separate impact of obesity and glucose tolerance on the incretin effect in normal subjects and type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2459-7

21 January 2018

The influence of GLP-1 on glucose-stimulated insulin secretion: effects on beta-cell sensitivity in type 2 and nondiabetic subjects

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2459-7

21 January 2018

Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2459-7

21 January 2018

Metabolic and genetic characterization of prediabetic states. Sequence of events leading to non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2459-7

21 January 2018

Risk and mechanism of dexamethasone-induced deterioration of glucose tolerance in non-diabetic first-degree relatives of NIDDM patients.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2459-7

21 January 2018

Accurate assessment of beta-cell function: the hyperbolic correction

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2459-7

21 January 2018

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2459-7

21 January 2018

Critical evaluation of the 'heated-hand-technique' for obtaining 'arterialized' venous blood: incomplete arterialization and alterations in glucagon responses

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2459-7

21 January 2018

Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2459-7

21 January 2018

Proglucagon products in plasma of noninsulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginine

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2459-7

21 January 2018

Validation of methods for measurement of insulin secretion in humans in vivo.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2459-7

21 January 2018

Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2459-7

21 January 2018

Hyperbolic relationship between insulin secretion and sensitivity on oral glucose tolerance test

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2459-7

21 January 2018

Secretion of incretin hormones (GIP and GLP-1) and incretin effect after oral glucose in first-degree relatives of patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2459-7

21 January 2018

Near normalisation of blood glucose improves the potentiating effect of GLP-1 on glucose-induced insulin secretion in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2459-7

21 January 2018

Immunoassays for the incretin hormones GIP and GLP-1.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2459-7

21 January 2018

Increased postprandial GIP and glucagon responses, but unaltered GLP-1 response after intervention with steroid hormone, relative physical inactivity, and high-calorie diet in healthy subjects.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2459-7

21 January 2018

Mechanisms of dexamethasone-induced insulin resistance in healthy humans.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2459-7

21 January 2018

Disproportionately elevated proinsulin levels reflect the degree of impaired B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2459-7

21 January 2018

beta-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2459-7

21 January 2018

Is the diminished incretin effect in type 2 diabetes just an epi-phenomenon of impaired beta-cell function?

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2459-7

21 January 2018

Reduced Incretin Effect in Type 2 Diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2459-7

21 January 2018

Diminished Immunoreactive Gastric Inhibitory Polypeptide Response to a Meal in Newly Diagnosed Type I (Insulin-Dependent) Diabetics*

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2459-7

21 January 2018

Evaluation of beta-cell secretory capacity using glucagon-like peptide 1

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2459-7

21 January 2018

Inappropriate suppression of glucagon during OGTT but not during isoglycaemic i.v. glucose infusion contributes to the reduced incretin effect in type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2459-7

21 January 2018

The heterogeneity of gastric inhibitory polypeptide in porcine and human gastrointestinal mucosa evaluated with five different antisera

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2459-7

21 January 2018

Glucagon-related peptides in the human gastrointestinal mucosa

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2459-7

21 January 2018

Circulating glucagon after total pancreatectomy in man

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2459-7

21 January 2018

Effect of hypercorticism on regulation of skeletal muscle glycogen metabolism by epinephrine

1 reference

https://pubmed.ncbi.nlm.nih.gov/22286551

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of glucocorticoid and growth hormone treatment on proinsulin levels in humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/22286551

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/22286551

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Highly sensitive enzyme immunoassay of proinsulin immunoreactivity with use of two monoclonal antibodies.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22286551

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hyperproinsulinemia in type II diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/22286551

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22286551

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Banting lecture 1990. Beta-cells in type II diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/22286551

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Incretin effects of increasing glucose loads in man calculated from venous insulin and C-peptide responses

1 reference

https://pubmed.ncbi.nlm.nih.gov/22286551

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Report of the expert committee on the diagnosis and classification of diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/22286551

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Basal and stimulated hyperinsulinism: reversible metabolic sequelae of obesity

1 reference

https://pubmed.ncbi.nlm.nih.gov/22286551

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of glucocorticoids on carbohydrate metabolism

1 reference

https://pubmed.ncbi.nlm.nih.gov/22286551

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proinsulin as a marker for the development of NIDDM in Japanese-American men.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22286551

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced incretin effect in type 2 (non-insulin-dependent) diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/22286551

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00125-012-2459-7

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/22286551

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/22286551

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51361908&oldid=1857944150"